1          Levosimendan is a new inotropic and vasodilator agent.

2 yridine (26.6 mm), was co-perfused with each vasodilator agent.

3 sponsiveness of fetal cerebral arterioles to vasodilator agents.

4 zation has mostly relied on antiplatelet and vasodilator agents.

5  both endothelium-dependent and -independent vasodilator agents are blunted in the leg compared to th

6 nd ETA receptor antagonists may be useful as vasodilator agents in CHF patients already receiving tre

7       Sildenafil and nitroglycerin (NTG) are vasodilator agents that may affect skin flap survival.

8 t (1) L-SNC is a more potent hypotensive and vasodilator agent within the mesenteric bed and sympathe